IVF discounts beat cash rewards for research eggs
By New Scientist,
New Scientist
| 07. 12. 2009
You can't get something for nothing, especially when it comes to acquiring women's eggs for medical research. But it is becoming clear that there are effective alternatives to cash payments, which are banned in several countries.
At the annual meeting of the International Society for Stem Cell Research in Barcelona, Spain, this week, Alison Murdoch of the International Centre for Life in Newcastle-upon-Tyne, UK, describes a successful "egg sharing" scheme. Women struggling to conceive can obtain IVF at a discounted rate, in exchange for donating some of their eggs for research.
Cash payments to egg donors are banned in the UK. But Murdoch's approach was approved by the Human Fertilisation and Embryology Authority and has worked like a charm. In 2008, Murdoch's team had 191 enquiries from interested women and ended up obtaining 199 eggs from 32 couples.
"We are getting donors and we are getting eggs," says Murdoch. The team is using the eggs in experiments into "therapeutic cloning", which could ultimately produce stem cells matched to individual patients.
Murdoch's success contrasts with the slim pickings obtained by researchers...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...